Search Results
Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC
Targeting BRAF in Metastatic CRC
Case 3: KRAS-Mutated Metastatic Colon Cancer
Novel Agents and Targets in Colorectal Cancer
Treating Metastatic Colorectal Cancer: Case Study Review
BRAF-Mutated mCRC: From Diagnosis to Treatment
Survival Differences in KRAS/BRAF Mutations in mCRC
Editorial - BRAF Mutation in Colorectal Cancer: An Enigmatic Target
Keynote Lecture 4: The BRAF pathway in CRC?
What is the optimal therapy for BRAF mutant metastatic colorectal cancer?
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies
Dr Ryan Corcoran from MGH talks about #BRAF mutated colorectal cancer updates in this #DocTalk
